Anders Jack 4
4 · Revolution Medicines, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-12-16$77.09/sh−3,104$239,289→ 108,065 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 175 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2025.
- [F3]Includes 42,338 restricted stock units.